✦ LIBER ✦

Dasatinib and nilotinib in first-line treatment of chronic myeloid leukemia

✍ Scribed by Jame Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Utility Analysis of Dasatinib and N

✍ Kulpeng, Wantanee; Sompitak, Sumalai; Jootar, Saengsuree; Chansung, Kanchana; Te 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 433 KB

First-line treatment for chronic myeloid

✍ Guoqing Wei; Shamudheen Rafiyath; Delong Liu 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 298 KB

First-line treatment of chronic myeloid

✍ Nicholas J. DiBella 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 108 KB

Dasatinib in the first-line treatment of

✍ Patricia Ault 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 264 KB

Adherence to treatment with second-line

✍ Yood, Marianne Ulcickas; Oliveria, Susan A.; Cziraky, Mark; Hirji, Ishan; Hamdan 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 206 KB